Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Horizon Therapeutics to acquire Viela Bio in deal with equity value of $3.05 billion
07:10am, Monday, 01'st Feb 2021
Horizon Therapeutics Plc said Monday it has agreed to acquire Viela Bio Inc. for $53 a share in cash, or an equity value of about $3.05 billion. The deal is expected to close by the end of the first q
DUBLIN & GAITHERSBURG, Md.--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) and Viela Bio, Inc. (Nasdaq: VIE) today announced the companies have entered into a definitive agreement under whic
7 Growth Stocks in The S&P's Hottest Sectors That Are Primed to Explode
07:10am, Friday, 22'nd Jan 2021
Growth stocks are a great way to make money. Here are seven of the stronger names in the S&P 500's hottest sectors for investors to consider.
Top Healthcare Stocks for February 2021
02:15pm, Tuesday, 19'th Jan 2021
These are the healthcare stocks with the best value, fastest growth, and most momentum for February 2021.
Horizon (HZNP) Provides Preliminary 2020 Financial Results
11:17am, Tuesday, 12'th Jan 2021
Horizon (HZNP) provides 2020 preliminary financial results and updates on its key drugs.
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced updates on its 2020 financial results, TEPEZZA supply and new KRYSTEXXA trials. “Amid the most challenging environmen
Horizon Therapeutics: Poised For Another Breakout
11:55am, Friday, 08'th Jan 2021
Horizon Therapeutics: Poised For Another Breakout
Selecta: ImmTOR Platform's Potential In Key
04:49am, Friday, 25'th Dec 2020
Selecta: ImmTOR Platform's Potential In Key
Horizon Therapeutics plc to Present at the 39th Annual J.P. Morgan Healthcare Conference
08:00am, Tuesday, 22'nd Dec 2020
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the 39th Annual J.P. Morgan Healthcare Conference. Tim Walbert, chairman, presiden
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) announced that it expects a short-term disruption in TEPEZZA (teprotumumab-trbw) supply as a result of recent government-mandated COVID
Horizon Therapeutics vs. Gilead
11:09am, Friday, 11'th Dec 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) and Gilead Sciences Inc (NASDAQ:GILD) are two contrasting stocks from the drug manufacturing industry, in my opinion. What they share is a price that has pulled
LAKE FOREST, Ill.--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has provided $500,000 in scholarships to Lake Forest College and created a $500,000 Horizon Therapeu
Great Place to Work Names Horizon Therapeutics plc to Best Workplaces for Parents List
09:15am, Wednesday, 02'nd Dec 2020
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has been named to Great Place to Work's 2020 Best Workplaces for Parents list, which highlights companies that
LAKE FOREST, Ill.--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has provided $1.2 million in additional funding to U.S and international organizations to support CO
HorizonTherapeutics (HZNP) Rises YTD on Approvals & Buyouts
08:25am, Friday, 27'th Nov 2020
Horizon Therapeutics (HZNP) expects continued strong growth for Krystexxa and Tepezza in 2021. It is making efforts to expand the label for its marketed drugs.
